GlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an immuno-oncology drug ... tally to a hefty €3.7 billion (around $4.2bn).

Existing investors and new investor Double Point Ventures join forces to support ImmunOs TherapeuticsInvestment secures funding of ongoing promising clinical trial of IOS-1002 in solid cancers ...

After more than a year of waiting, season 3 is nearly here, and we'll finally get to see what happens after that shock ending to season 2. Season 2 left us on a major cliffhanger, with the finale ...

After hours: September 20 at 7:59 PM EDT Loading Chart for AIM ...

Bharat Immunological & Biologicals Corporation Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 126.91 Crore) operating in Pharmaceuticals sector. Bharat ...